These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6600741)

  • 21. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D; Simonet M; Veron M
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acid.
    Diver JM; Thornber D; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):89-92. PubMed ID: 2550415
    [No Abstract]   [Full Text] [Related]  

  • 24. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular aspects of beta-lactamase inhibition and inactivation by clavulanic acid: a review.
    Labia R; Barthélemy M; Peduzzi J
    Drugs Exp Clin Res; 1985; 11(11):765-70. PubMed ID: 3915466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen LW
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient state kinetic studies on catalysis and inhibition of staphylococcal beta-lactamase.
    Virden R
    J Chemother; 1991 Apr; 3(2):79-82. PubMed ID: 1875236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid encoded beta-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms.
    Hunter JE; Corkill JE; McLennan AG; Fletcher JN; Hart CA
    Res Vet Sci; 1993 Nov; 55(3):367-70. PubMed ID: 8284502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of clavulanic acid and beta-lactamase on phagocytosis of Staphylococcus aureus.
    Martínez-Martínez L; Pascual A; Conejo MC; Perea EJ
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):783-4. PubMed ID: 2261924
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 33. Inactivation of amoxycillin, clavulanate and the combination by faecal preparations from volunteers.
    Welling GW; Groen G
    J Antimicrob Chemother; 1990 Feb; 25(2):301-2. PubMed ID: 2329109
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM; Seetulsingh P
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Pathol Biol (Paris); 1987 May; 35(5):526-30. PubMed ID: 3302856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL; Jones RN; Packer RR
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity.
    Martín M; Aguilar L; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):290-2. PubMed ID: 9069559
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of amoxycillin and clavulanic acid, alone and in combination, on human polymorphonuclear leukocyte function against Staphylococcus aureus.
    Pascual A; Martínez Martínez L; Aragón J; Perea EJ
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):277-81. PubMed ID: 2540981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.